|
|
| MRD / Regn No. |
: THBC\23-24\01989 |
Date |
: 29/06/2026 |
| Patient Name |
: Tabassum Reshamvala |
Age & Gender |
: 62 Yrs. / Female |
| Contact No. |
: 9833391264 |
UHID |
: |
| Ht / Wt / BMI |
: 160.5 / 68.35 / 26.53 |
BP S / BP D |
: 122 / 81 |
| Allergies |
: NONE |
Referred By |
: |
| |
|
|
Subjective |
: |
T2DM X 15 YEARS,B/L TKR IN JULY 2024,SLIGHT ITCHING / BURNING / SMALL NO OF PUS CELLS,RECENT PTCA
|
|
Objective |
: |
23-JUN-2026 REPORTS,FBS-155/ PPBS-190,HBA1C-8.5% |
|
Plan |
: |
RETINA TEST FOR DIABETIC RETINOPATHY - DR PRAKASH NAYAK,WILL CHANGE FROM AJADUO TO GIBTULIO |
|
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET GLIMEPRIDE 3 MG
AMARYL 3 MG |
ORAL |
1-0-1 |
BBF /BD
|
3 MTHS |
|
|
2 |
CARDACE PROTECT 2.5 |
ORAL |
0-0-1 |
AD
|
3 MTHS |
|
|
3 |
DRISE 60,000 |
ORAL |
1/15 DAYS |
ANYTIME OF DAY
|
3 MTHS |
|
|
4 |
LANTUS |
ORAL |
0-0-38 |
11 PM BEDTIME
|
3 MTHS |
|
|
5 |
CCM |
ORAL |
0-1-0 |
AL
|
3 MTHS |
|
|
6 |
INJ OZEMPIC 0.25 MG |
SC |
1/WEEK |
ANYTIME OF DAY
|
4 WEEKS |
|
|
7 |
INJ OZEMPIC 0.5 MG |
SC |
0.5 MG / WEEK |
ANYTIME OF DAY
|
4 WEEKS |
|
|
8 |
TABLET EMPAGLIFLOZIN 25 MG
GIBTULIO 25 MG |
ORAL |
1-0-0 |
ABF
|
3 MTHS |
|
|
9 |
CAP SOMPRAZ D 40 |
ORAL |
1-0-0 |
BBF
|
3 MTHS |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL. |
| Next Visit |
: 29/Aug/2026 |
| Tests Suggested For Next Visit |
: HBA1C > 2 MTHS,FBS / PPBS EVERY WEEK 2 DAYS AFTER INJECTION |
| |
|
| |
|
Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra /
2003/05/2166
This is a Computer generated Prescription |
Powered By:  |